Term Section Term Section Clause Samples
Term Section Term Section. Escrow Release Date 1.15(c) Registration Rights Agreement Recitals Escrow Shares 1.15(a) Registration Statement 5.12(a) Escrowed Seller Preamble Related Person 4.21 Expenses 7.3 Released Claims 8.1 Extension 5.3(a) Required Company Stockholder Approval 6.1(b) Extension Expenses 5.3(a)(iv) Required SPAC Shareholder Approval 6.1(a) Extension Redemption 3.5(c) SEC Filing Fee Expenses 7.3 Fairness Opinion 5.20 SEC Reports 3.6(a) Federal Securities Laws 5.7 SEC SPAC Accounting Changes 3.6(a) Final Determination Date 1.15(g) Section 409A Plan 4.19(k) Forfeiture Event 1.15(b) Sensitive Information 4.13(f) Forfeiture Notice 1.15(c) Signing Filing 5.14(b) Incentive Plan 5.12(a) Signing Press Release 5.14(b) Interim Balance Sheet Date 4.7(a) SPAC Preamble Interim Period 5.1(a) SPAC D&O Tail Insurance 5.17(b) Letter of Transmittal 1.10(a) SPAC Directors 5.16(a) Lock-Up Agreement Recitals SPAC Disclosure Schedules Article III Lost Certificate Affidavit 1.10(d) SPAC Expenses 7.3 Merger Recitals SPAC Extraordinary General Meeting 5.12(a) Merger Consideration 1.8 SPAC Financials 3.6(b) Merger Consideration Shares 1.8 SPAC Material Contract 3.13(a) Merger Sub Preamble SPAC Representative Preamble Non-Competition Agreement Recitals SPAC Representative Documents 9.16(a) NRS Recitals SPAC Shareholder Approval Matters 5.12(a) Objection Notice 1.15(d) SPAC Termination Fee (a) OFAC 3.19(c) Specified Courts 9.6 Ortoli 9.15(b) Sponsor Preamble Outside Date 7.1(b) Subject Payments 1.15(b) Party(ies) Preamble Surviving Corporation 1.1 PIPE Financing Agreements 5.19(a) Top Customers 4.23 PIPE Investment 5.19(a) Top Suppliers 4.23 Transaction Financing 5.19(b)(iii) Transmittal Documents 1.10(b) Transaction Financing Agreements 5.19(b)(iii) Voting Agreements Recitals Post-Closing SPAC Board 5.16(a) Proxy Statement 5.12(a) Public Certifications 3.6(a) Public Shareholders 8.1 Redemption 3.5(c)
Term Section Term Section. Dispute 9.6 Plans of Merger 1.4 Effective Time 1.4 Post-Closing Pubco Board 5.15(a) EGS 9.16(a) Proxy Statement 5.11(a)
Term Section Term Section. Expenses 6 .18 Pharmaceutical Product 5 .24(a) Extension 6.3(b)(iv) Post-Closing Pubco Board 6.16(a) Extension Redemption 3.5(b) Proxy Statement 6.11(a)
Term Section Term Section. 15D Exemption 6.22(a) Company Benefit Plan 5.19(a) 2023/2022 Audited Financials 5.7(a) Company Certificate of Merger 1.3 AAA Procedures 10.6 Company Certificates 1.14(a) Accounts Receivable 5.7(f) Company DeSPAC Advisors 8.3 Acquisition Proposal 6.6(a) Company Disclosure Schedules Article V Additional Financing Agreements 6.19(b) Company Financials 5.7(a) Additional Transaction Financing 6.19(b) Company IP 5.13(d) Agreement Preamble Company IP Licenses 5.13(a) Alternative Transaction 6.6(a) Company Material Contract 5.12(a) Amended Pubco Organizational Company Merger Recitals Documents 1.7 Company Merger Effective Time 1.3 Amended Registration Rights Company Merger Sub Preamble Agreement Recitals Company Permits 5.10 Antitrust Laws 6.9(b) Company Personal Property Leases 5.16 Audited Financials 5.7(a) Company Plan of Merger 1.3 Bridge Financing 6.19(a) Company Real Property Leases 5.15 Bridge Financing Agreements 6.19(a) Company Registered IP 5.13(a)
Term Section Term Section. Acquisition Proposal 7.6(a) Company Material Contract 6.12(a) Additional Information 7.21 Company Permits 6.10 Additional Review 7.21 Company Real Property Leases 6.15 Additional Review Period 7.21 Company Registered IP 6.13(a) Agreement Preamble Company Share Consideration 2.1(b) Alternative Transaction 7.6(a) D&O Indemnified Person 7.15(a) Balance Sheet Date 6.7(a) D&O Tail Insurance 7.15(b) Business Combination 11.1 Effective Time 1.2(b) Cap 4.6(h) EGS 3.1 Closing 3.1 Equity Incentive Plan 7.11(a) Closing Date 3.1 Enforceability Exceptions 4.2 Closing Filing 7.12(b) Environmental Permits 6.20(a) Closing Press Release 7.12(b) Expenses 10.3(a) Company Preamble Expiration Date 9.1 Company Benefit Plan 6.19(a) Extension 7.3(a) Company Board 7.6(d) Extension Loan 7.18 Company Certificate 2.5(b) Federal Securities Laws 7.7 Company Class A Ordinary Shares 6.3(a) Final EY Report Schedule 7.21 Company Class B Ordinary Shares 6.3(a) First Merger Recitals Company Directors 7.14(a) First Merger Documents 1.2(a) Company Disclosure Schedules ARTICLE VI First Merger Effective Time 1.2(a) Company Financials 6.7(a) First Merger Plan of Merger 1.2(a) Company IP 6.13(c) First Merger Sub Preamble Company IP Licenses 6.13(a) Founder Lock-up Agreement Recitals Founders Recitals
Term Section Term Section. PIPE Investors Recitals Required Purchaser Shareholder Approval 6.1(a) PIPE Shares Recitals Reviewed 2nd Quarter Company Financials 5.4(a) Post-Closing Purchaser Board 5.17(a) Sales Earnout Milestones 1.11(a)(ii) Price Earnout Milestone 1.11(a)(iii) Sales Earnout Statement 1.11(c)
Term Section Term Section. Specified Courts 11.5 WFOE Recitals Supplemental Disclosure Schedules 6.17(a) Termination Fee 9.4 Top Customers 4.23
Term Section Term Section. Closing Date 2.1 Pro Rata Share 1.4 Company Preamble Prohibited Transfer 6.7 Dispute 8.10 Related Person 3.18 Effective Time 1.2 Resolution Period 8.10 Employment Agreements 2.2(g) RHI Software 3.10(b) Financial Statements 3.5(a) SEC Reports 5.5(a) Indemnification Cap 7.5 Seller Indemnified Parties 7.3 Indemnitee 7.4(a) Seller Parties Preamble Indemnitor 7.4(a) Seller Representative Preamble Loss 7.2 Sellers Preamble Material Contract 3.14(a) Shareholder Agreement 6.9 Merger Recitals Special Reps 7.1
Term Section Term Section. Indemnification Cap 9.4 Principal 2.2(k)(vi)
Term Section Term Section. Released Claims 8.1 Seller Representative Documents 9.17(a) Representative Party 1.12(b) Signing Filing 5.14(b) Required Company Stockholder Approval 7.2(b) Signing Press Release 5.14(b) Required Purchaser Stockholder Approval 6.1(a) SPAC Accounting Changes 3.6(a) Resolution Period 9.6 Specified Courts 9.7 Restricted Shares 1.13(a) Surviving Corporation 1.1 Revenue Milestone 1.13(c)(iii)(A) Termination Fee 7.4 Revenue and Franchise Statement 1.13(e)(ii) Third Tranche 1.13(c)(iii)